Showing 1081-1090 of 1690 results for "".
Alzheimer’s Disease Drug Development & Emerging Therapies
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/alzheimers-disease-drug-development-emerging-therapies/31541/We must all work together to accelerate clinical trials and create meaningful new therapies for Alzheimer’s disease.Care of Individuals with Neurofibromatosis Type 1 Amid an Evolving Paradigm of Therapeutic Development
https://practicalneurology.com/diseases-diagnoses/neuro-oncology/care-of-individuals-with-neurofibromatosis-type-1-amid-an-evolving-paradigm-of-therapeutic-development/35583/Treatment for individuals with neurofibromatosis type 1, a complex disease with variabilities in presentation and disease course, requires a multidisciplinary approach with emphasis on surveillance along with ongoing discussion of therapeutic interventions.Real-World Experience Using Biomarker Testing for the Evaluation of Acute Traumatic Brain Injury
https://practicalneurology.com/diseases-diagnoses/imaging-testing/real-world-experience-using-biomarker-testing-for-the-evaluation-of-acute-traumatic-brain-injury/32184/Integrating blood biomarker testing for traumatic brain injury into practice can help address some limitations with existing evaluative methods, leading to more timely and cost-effective diagnosis and improved health-related quality of life for affected individuals.The Whole Physician: Ten Action Items to Combat Peer-to-Peer and Institutional Racial Bias in Medicine
https://practicalneurology.com/columns/practice-management/the-whole-physician-ten-action-items-to-combat-peer-to-peer-and-institutional-racial-bias-in-medicine/32106/Biases that exist in medicine can be remedied with actions tailored to the individual, specific groups, and society at large.The Science Behind FcRn Antagonists: A Deep Dive Into Their Mechanism of Action
https://practicalneurology.com/programs/cme/the-science-behind-fcrn-antagonists-a-deep-dive-into-their-mechanism-of-action/32241/While traditional gMG treatments bring many debilitating side effects, a more targeted approach focusing on the FcRn complex has shown great promise.Case Report: Noninvasive Intracranial Pressure Monitoring
https://practicalneurology.com/diseases-diagnoses/imaging-testing/case-report-noninvasive-intracranial-pressure-monitoring/31804/Global cerebral edema secondary to acute hyponatremia illustrates the use of noninvasive intracranial pressure monitoring.Multiple Sclerosis in People Over Age 55
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-in-people-over-age-55/31759/The average age of people with MS is increasing, but knowledge of the disease in people over age 55 remains sparse.Antisense Oligonucleotide Therapies
https://practicalneurology.com/diseases-diagnoses/movement-disorders/antisense-oligonucleotide-therapies/31573/Antisense oligonucleotides are a promising new therapeutic class being studied for the treatment of movement disorders.Case Report: Cerebral Aneurysm Rerupture
https://practicalneurology.com/diseases-diagnoses/stroke/case-report-cerebral-aneurysm-rerupture/31817/Antifibrinolytic therapy may induce cerebral aneurysmal thrombosis that can obscure unstable aneurysms, delaying diagnosis and treatment.Headache Disorders: Lifestyle & Behavioral Management
https://practicalneurology.com/diseases-diagnoses/headache-pain/headache-disorders-lifestyle-behavioral-management/31771/Nonmedication treatment may address triggers and symptoms of headache disorders.